Equities

Autobio Diagnostics Co Ltd

603658:SHH

Autobio Diagnostics Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)38.36
  • Today's Change-7.35 / -16.08%
  • Shares traded2.00m
  • 1 Year change-17.72%
  • Beta0.6110
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.

  • Revenue in CNY (TTM)4.58bn
  • Net income in CNY1.27bn
  • Incorporated1999
  • Employees5.54k
  • Location
    Autobio Diagnostics Co LtdNo.87 Jingbei Yi Rd.National Eco, Zhengzhou, Henan 450016ZHENGZHOU 450016ChinaCHN
  • Phone+86 37 186506868
  • Fax+86 37 186506767
  • Websitehttps://www.autobio.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Haohai Biological Tech Co Ltd2.75bn430.21m14.30bn2.16k36.542.83--5.201.861.8611.8924.070.38331.607.601,272,966.005.604.846.605.5068.9772.0414.6116.363.71--0.069736.8624.5911.24130.580.076211.96--
Beijing Balance Medical Technolgy Co Ltd405.57m103.55m16.49bn473.00159.3414.07--40.650.75310.75312.968.530.31831.094.94857,444.607.148.067.468.4088.3189.4122.4230.028.22--0.009169.1925.5727.3521.0928.10125.94--
iRay Technology Co Ltd1.82bn564.72m17.08bn1.66k31.983.72--9.373.743.7412.1432.150.25441.032.561,097,588.007.8112.078.4813.8653.9255.5930.7134.514.23--0.397231.5220.3133.51-5.2758.58107.96--
Eyebright Medical Tchnlgy Beijing Co Ltd1.36bn369.60m18.86bn2.07k50.968.09--13.891.951.957.1712.290.45992.404.64654,939.8011.739.9913.2911.1665.5881.2925.5034.663.7641.180.190419.9164.1449.5930.6371.8038.83--
MGI Tech Co Ltd2.58bn-873.08m21.28bn2.87k--2.66--8.26-2.12-2.126.2619.210.24670.77452.87898,663.20-8.40---9.62--59.99---34.04--3.99--0.0766---31.19---129.98------
Autobio Diagnostics Co Ltd4.58bn1.27bn26.56bn5.54k20.833.16--5.802.192.197.9014.460.40791.913.93827,079.5011.3812.5914.5415.7964.9361.6227.9026.962.18--0.109346.400.045718.154.2816.7017.0311.32
APT Medical Inc1.96bn658.82m33.00bn2.16k50.0813.81--16.826.776.7720.1424.540.74751.4936.01910,130.4024.6818.1230.7121.9471.1370.3033.0227.073.05--0.005126.4935.7146.8349.1390.0944.39--
Data as of Sep 13 2024. Currency figures normalised to Autobio Diagnostics Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

6.83%Per cent of shares held by top holders
HolderShares% Held
Zhong Geng Fund Management Co. , Ltd.as of 30 Sep 202314.81m2.53%
Hwabao WP Fund Management Co., Ltd.as of 29 Jan 20246.77m1.16%
UBS AG (Investment Management)as of 30 Sep 20234.12m0.70%
China Southern Asset Management Co., Ltd.as of 30 Jun 20243.06m0.52%
First Sentier Investors (UK) IM Ltd.as of 31 Jul 20242.73m0.47%
China Universal Asset Management Co., Ltd.as of 30 Jun 20242.29m0.39%
Guotai Asset Management Co., Ltd.as of 30 Jun 20241.97m0.34%
GF Fund Management Co., Ltd.as of 30 Jun 20241.51m0.26%
China Fund Management Co., Ltd.as of 30 Jun 20241.45m0.25%
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 20241.34m0.23%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.